Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Byington

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Controlled Clinical Trials|December 1, 1984
Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research groupR P Byington
American Journal of Epidemiology|April 1, 1985
Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack TrialL M Friedman, R P Byington
Circulation|June 1, 1983
What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experienceC D Furberg, R P Byington
American Journal of Hypertension|February 1, 1991
MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline dataW B Applegate, R P Byington
Cardiovascular Clinics|January 1, 1989
Beta-adrenergic blockers in patients with acute myocardial infarctionC D Furberg, R P Byington
JAMA|March 22, 1985
Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack TrialR P Byington, J D Curb, M E Mattson
Atherosclerosis|July 25, 1998
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataJ R Crouse, R P Byington, C D Furberg
The American Journal of Medicine|April 17, 1989
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research GroupC D Furberg, R P Byington, N A Borhani
Journal of Cardiovascular Pharmacology|January 1, 1990
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research GroupN O Borhani, S B Brugger, R P Byington
The American Journal of Cardiology|June 1, 1990
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experienceR P Byington, J Worthy, T Craven, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Controlled Clinical Trials|December 1, 1984
Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research groupR P Byington
American Journal of Epidemiology|April 1, 1985
Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack TrialL M Friedman, R P Byington
Circulation|June 1, 1983
What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experienceC D Furberg, R P Byington
American Journal of Hypertension|February 1, 1991
MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline dataW B Applegate, R P Byington
Cardiovascular Clinics|January 1, 1989
Beta-adrenergic blockers in patients with acute myocardial infarctionC D Furberg, R P Byington
JAMA|March 22, 1985
Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack TrialR P Byington, J D Curb, M E Mattson
Atherosclerosis|July 25, 1998
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials dataJ R Crouse, R P Byington, C D Furberg
The American Journal of Medicine|April 17, 1989
Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research GroupC D Furberg, R P Byington, N A Borhani
Journal of Cardiovascular Pharmacology|January 1, 1990
Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research GroupN O Borhani, S B Brugger, R P Byington
The American Journal of Cardiology|June 1, 1990
Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experienceR P Byington, J Worthy, T Craven, et al.
Pageof 4